APA (7th ed.) Citation

Murphy, S. C., Deye, G. A., Sim, B. K. L., Galbiati, S., Kennedy, J. K., Cohen, K. W., . . . Jackson, L. A. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Murphy, Sean C., et al. PfSPZ-CVac Efficacy Against Malaria Increases from 0% to 75% When Administered in the Absence of Erythrocyte Stage Parasitemia: A Randomized, Placebo-controlled Trial with Controlled Human Malaria Infection. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Murphy, Sean C., et al. PfSPZ-CVac Efficacy Against Malaria Increases from 0% to 75% When Administered in the Absence of Erythrocyte Stage Parasitemia: A Randomized, Placebo-controlled Trial with Controlled Human Malaria Infection. Public Library of Science (PLoS).